- Conditions
- Restless Legs Syndrome
- Interventions
- NTX100 Neuromodulation System - Active, NTX100 Neuromodulation System - Sham
- Device
- Lead sponsor
- Noctrix Health, Inc.
- Industry
- Eligibility
- 22 Years to 89 Years
- Enrollment
- 58 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 3
- States / cities
- Menlo Park, California • San Ramon, California • St Louis, Missouri
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 289–312
of 4,796
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Dry Eye
- Interventions
- Lifitegrast Ophthalmic Solution 5.0% (Xiidra)
- Drug
- Lead sponsor
- Toyos Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Cervical Neoplasms, Human Papillomavirus
- Interventions
- BD HPV Assay on Viper LT, Colposcopy
- Device · Procedure
- Lead sponsor
- Becton, Dickinson and Company
- Industry
- Eligibility
- 21 Years and older · Female only
- Enrollment
- 6,730 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2019
- U.S. locations
- 39
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 35 more
- Conditions
- Healthy
- Interventions
- Enlicitide decanoate
- Drug
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023
- U.S. locations
- 1
- States / cities
- Lincoln, Nebraska
- Conditions
- Myocardial Fibrosis, Cardiovascular Disease
- Interventions
- Traminer MRI Sequence
- Other
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- Park Ridge, Illinois
- Conditions
- Crohn's Disease
- Interventions
- Placebo, PROCHYMAL adult human mesenchymal stem cells
- Drug
- Lead sponsor
- Mesoblast, Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 98 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2011
- U.S. locations
- 53
- States / cities
- Anaheim, California • Long Beach, California • Los Angeles, California + 44 more
- Conditions
- Urinary Tract Infections
- Interventions
- Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine medium dose formulation 1, Candidate UTI vaccine medium dose formulation 2, Candidate UTI vaccine high dose formulation 1, Candidate UTI vaccine high dose formulation 2, Candidate UTI vaccine HTD formulation 2, Placebo
- Combination Product
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 465 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 9
- States / cities
- Lenexa, Kansas • Covington, Louisiana • Secaucus, New Jersey + 6 more
- Conditions
- Bacterial Infection
- Interventions
- MBN-101, Placebo
- Drug · Other
- Lead sponsor
- Microbion Corporation
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 6
- States / cities
- San Francisco, California • Baltimore, Maryland • Columbus, Ohio + 2 more
- Conditions
- Wound Healing
- Interventions
- Mepilex Transfer Ag
- Device
- Lead sponsor
- Molnlycke Health Care AB
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 2
- States / cities
- Tampa, Florida • Garden City, New York
- Conditions
- Stroke, Acute, Gait, Hemiplegic
- Interventions
- MRI, blood draw, Clinical assessments
- Diagnostic Test · Other
- Lead sponsor
- University of Vermont
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Burlington, Vermont
- Conditions
- Pancreatitis, Chronic, Abdominal Pain
- Interventions
- EUS-celiac ganglia block (EUS-CGB), EUS-celiac plexus block (EUS-CPB)
- Procedure
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- HIV Infections
- Interventions
- DNA CON-S env, IHV01, Placebo
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 50 Years
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Blood Stream Infection, Blood Stream Infections, Sepsis, Fungemia, Bacteremia
- Interventions
- UllCORE BSI Test
- Diagnostic Test
- Lead sponsor
- Deepull Diagnostics S.L.
- Industry
- Eligibility
- Not listed
- Enrollment
- 1,500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 10
- States / cities
- Orange, California • Tampa, Florida • Baltimore, Maryland + 7 more
- Conditions
- Cardiac Arrest, Sudden
- Interventions
- ASSURE™ Wearable Cardioverter Defibrillator (WCD)
- Device
- Lead sponsor
- Kestra Medical Technologies, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 10
- States / cities
- Anchorage, Alaska • Hammond, Louisiana • Takoma Park, Maryland + 7 more
- Conditions
- Cardiovascular Diseases
- Interventions
- Atorvastatin
- Drug
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 160 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Healthy Subjects, Exosome, Targeted Therapy
- Interventions
- SOB100
- Drug
- Lead sponsor
- Shine-On Biomedical Co., Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 15 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- HER2-Positive Solid Tumor
- Interventions
- YH32367
- Drug
- Lead sponsor
- Yuhan Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 147 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2028
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts • Nashville, Tennessee
- Conditions
- HIV Infections
- Interventions
- VRC07-523LS
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 28 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts • Seattle, Washington
- Conditions
- Solid Tumor, Advanced Solid Tumor
- Interventions
- PYX-201
- Drug
- Lead sponsor
- Pyxis Oncology, Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 330 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 17
- States / cities
- Scottsdale, Arizona • Los Angeles, California • Denver, Colorado + 13 more
- Conditions
- Cervical Degenerative Disc Disorder
- Interventions
- Simplify Disc
- Device
- Lead sponsor
- NuVasive
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 182 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 18
- States / cities
- Orange, California • Santa Monica, California • Thornton, Colorado + 15 more
- Conditions
- Endometriosis-related Pain
- Interventions
- Gefapixant, Placebo, Naproxen
- Drug
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Eligibility
- 18 Years to 49 Years · Female only
- Enrollment
- 187 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 30
- States / cities
- Birmingham, Alabama • Chandler, Arizona • Scottsdale, Arizona + 25 more
- Conditions
- Heart Failure
- Interventions
- EASYTRAK 3 Downsize Lead
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Saint Paul, Minnesota
- Conditions
- Glioblastoma
- Interventions
- Durvalumab, Standard radiotherapy, Bevacizumab
- Drug · Radiation · Biological
- Lead sponsor
- Ludwig Institute for Cancer Research
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 159 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 7
- States / cities
- Los Angeles, California • San Francisco, California • Baltimore, Maryland + 3 more
- Conditions
- CORNEAL OPACITY WITH POOR PROGNOSIS FOR CORNEAL TRANSPLANT
- Interventions
- Experimental
- Other
- Lead sponsor
- University of California, Irvine
- Other
- Eligibility
- 88 Years to 88 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Irvine, California